Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy for cognitive function in postmenopausal women.

E Hogervorst1, K Yaffe, M Richards

  • 1Pharmacology, University of Oxford, Oxford Project To Investigate Memory and Ageing, Radcliffe Infirmary, Woodstock Road, Oxford, UK, OX2 6HE. eva.hogervorst@linacre.ox.ac.uk

The Cochrane Database of Systematic Reviews
|July 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Could Alcohol Anticipation-Related Glucose Responses Contribute to a Physiological Drive to Consume Alcohol?

Substance use & misuse·2025
Same author

CT and MRI activity in England: insights from the diagnostic imaging dataset.

Clinical radiology·2025
Same author

Longitudinal associations of psychological distress with subsequent cognitive decline and dementia: a multi-cohort study.

medRxiv : the preprint server for health sciences·2025
Same author

Non-employment over the working life: Implications for cognitive function and decline in later life.

Public health in practice (Oxford, England)·2025
Same author

How far? Travel burdens for children admitted to hospitals in the Western Cape Province of South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

Musculoskeletal injury or Sports-Related Concussion (SRC) in a season of rugby union does not affect performance on concussion battery testing in university-aged student-athletes.

Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine·2024

Estrogen therapy (ERT) or hormone therapy (HRT) showed limited benefits for overall cognitive function in postmenopausal women. However, some improvements were noted in younger, surgically menopausal women receiving specific estradiol injections.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Estrogens play a role in maintaining brain structures, suggesting potential cognitive benefits for postmenopausal women.
  • Maintaining high estrogen levels may offer protection against age-related cognitive decline.

Purpose of the Study:

  • To evaluate the impact of estrogen-only therapy (ERT) or combined hormone therapy (HRT) versus placebo on cognitive function in postmenopausal women.
  • To synthesize findings from randomized controlled trials (RCTs) investigating hormone therapy and cognition.

Main Methods:

  • Systematic search of multiple databases (CDCIG, MEDLINE, EMBASE, PsycINFO, CINAHL) up to May 2002.
  • Inclusion of double-blind RCTs with a minimum treatment duration of two weeks.
  • Independent review and data extraction by multiple researchers to ensure study quality and validity.

Related Experiment Videos

Main Results:

  • Meta-analyses indicated positive effects of 10 mg estradiol (E2) injections on immediate recall, abstract reasoning, and speed/accuracy in young, surgically menopausal women.
  • Most studies found no significant cognitive benefits from ERT or HRT on verbal memory, visuospatial memory, or other cognitive measures.
  • Limited evidence supported positive effects of Premarin (a common estrogen) on cognitive function.

Conclusions:

  • Overall, evidence for ERT/HRT improving cognitive function in healthy postmenopausal women is limited.
  • Specific positive effects were observed in small studies on younger, surgically menopausal women with monthly E2 injections.
  • Further research is needed to determine if age, menopause type, treatment type, delivery method, dosage, or duration influence cognitive outcomes.